Division of Respiratory and Allergy Medicine, Komaki City Hospital, 1-20 Johbuji, Komaki, Japan.
Respir Med. 2011 Oct;105(10):1531-6. doi: 10.1016/j.rmed.2011.03.009. Epub 2011 Mar 30.
BACKGROUND: Little is known about the relationship between acute exacerbations of COPD (AECOPD) and gastroesophageal reflux disease (GERD). The aim of this study was to investigate the effects on AECOPD of GERD diagnosed by a questionnaire. METHODS: The subjects were 221 consecutive patients with stable COPD who were evaluated using the Frequency Scale for Symptoms of GERD (FSSG) and a prospective survey of AECOPD for one year. Patients taking drugs for acid suppression were excluded. The association between the frequency of AECOPD and the presence of GERD or FSSG score was examined. RESULTS: Based on the FSSG, the prevalence of GERD was 26.7%. AECOPD and hospitalization due to AECOPD were significantly more frequent in patients with GERD than in those without GERD, with crude relative risks of 3.42 and 3.66, respectively. Multivariate analyses showed that GERD and COPD stage IV were significant predictors of hospitalization due to AECOPD, independent of respiratory therapies or patient characteristics. The severity of GERD symptoms, as measured by the FSSG score, was significantly correlated with the frequencies of AECOPD and hospitalization due to AECOPD. Similar correlations were seen for the FSSG subscores for acid reflux and gastric dysmotility. CONCLUSIONS: This prospective cohort study showed that GERD appears to be a predictive factor for hospitalization due to AECOPD and that severer GERD symptoms may be associated with more frequent AECOPD. Thus, further studies are warranted to evaluate the preventive effect of the therapy for GERD on AECOPD.
背景:关于慢性阻塞性肺疾病(COPD)急性加重(AECOPD)与胃食管反流病(GERD)之间的关系知之甚少。本研究旨在通过问卷诊断 GERD 来探讨其对 AECOPD 的影响。
方法:研究对象为 221 例连续稳定期 COPD 患者,采用 GERD 症状频率量表(FSSG)和前瞻性调查对 AECOPD 进行为期一年的评估。排除服用抑酸药物的患者。检查 AECOPD 频率与 GERD 存在或 FSSG 评分之间的关系。
结果:根据 FSSG,GERD 的患病率为 26.7%。GERD 患者的 AECOPD 和因 AECOPD 住院的频率明显高于无 GERD 的患者,粗相对风险分别为 3.42 和 3.66。多变量分析显示,GERD 和 COPD Ⅳ期是因 AECOPD 住院的独立预测因子,与呼吸治疗或患者特征无关。FSSG 评分测量的 GERD 症状严重程度与 AECOPD 和因 AECOPD 住院的频率显著相关。FSSG 评分对于酸反流和胃动力障碍的亚评分也存在类似的相关性。
结论:这项前瞻性队列研究表明,GERD 似乎是因 AECOPD 住院的预测因子,更严重的 GERD 症状可能与更频繁的 AECOPD 相关。因此,需要进一步研究评估 GERD 治疗对 AECOPD 的预防作用。
J Gastrointestin Liver Dis. 2010-9
J Gastroenterol Hepatol. 2009-10-8
J Gastroenterol. 2004-9
Am J Gastroenterol. 2004-5
Int J Chron Obstruct Pulmon Dis. 2020
Int J Chron Obstruct Pulmon Dis. 2018-9-19
Tuberc Respir Dis (Seoul). 2018-10
Tuberc Respir Dis (Seoul). 2017-10